GlassScriptPhysician profile
Adam R Oppenheim
NPI 1316386865
$3,662.49
in general payments reported to CMS, 2019-2025
39 companies · $590 in 2025
The $590 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $493 · 2020: $210 · 2021: $174 · 2022: $419 · 2023: $1,006 · 2024: $769 · 2025: $590.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,366.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,366.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $402.21 | 2019-2024 | Xtandi, Myrbetriq |
| Medtronic, INC. | $323.59 | 2021-2025 | Interstim |
| Janssen Biotech, INC. | $291.11 | 2023-2025 | Erleada |
| Coloplast Corp | $258.59 | 2019-2023 | Titan |
| Boston Scientific Corporation | $218.68 | 2019-2023 | Spaceoar Vue System - 10ml |
| Abbvie INC. | $176.59 | 2019-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $170.65 | 2023-2025 | |
| Sumitomo Pharma America, INC. | $163.86 | 2023-2024 | Gemtesa, Orgovyx |
| Dendreon Pharmaceuticals LLC | $154.36 | 2022-2025 | Provenge |
| Procept Biorobotics Corporation | $108.74 | 2023-2024 | Aquabeam Robotic System, Aquabeam System |
| Pfizer INC. | $100.11 | 2019-2024 | |
| Urogen Pharma, INC. | $97.64 | 2022-2024 | |
| Karl Storz Endoscopy-America | $96.18 | 2025 | |
| Neotract INC. | $96.13 | 2019 | |
| Novartis Pharmaceuticals Corporation | $93.49 | 2023-2025 |
Show all 39 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adam Oppenheim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.